key: cord-0871600-ym9zy33k
authors: Cihan, Pınar; Ozger, Zeynep Banu
title: A new approach for determining SARS-CoV-2 epitopes using machine learning-based in silico methods
date: 2022-04-30
journal: Comput Biol Chem
DOI: 10.1016/j.compbiolchem.2022.107688
sha: 8e9a4bf4b0d715e56cf8b875dd9988084c905e8c
doc_id: 871600
cord_uid: ym9zy33k

The emergence of machine learning-based in silico tools has enabled rapid and high-quality predictions in the biomedical field. In the COVID-19 pandemic, machine learning methods have been used in many topics such as predicting the death of patients, modeling the spread of infection, determining future effects, diagnosis with medical image analysis, and forecasting the vaccination rate. However, there is a gap in the literature regarding identifying epitopes that can be used in fast, useful, and effective vaccine design using machine learning methods and bioinformatics tools. Machine learning methods can give medical biotechnologists an advantage in designing a faster and more successful vaccine. The motivation of this study is to propose a successful hybrid machine learning method for SARS-CoV-2 epitope prediction and to identify nonallergen, nontoxic, antigen peptides that can be used in vaccine design from the predicted epitopes with bioinformatics tools. The identified epitopes will be effective not only in the design of the COVID-19 vaccine but also against viruses from the SARS family that may be encountered in the future. For this purpose, epitope prediction performances of random forest, support vector machine, logistic regression, bagging with decision tree, k-nearest neighbor and decision tree methods were examined. In the SARS-CoV and B-cell datasets used for education in the study, epitope estimation was performed again after the datasets were balanced with the synthetic minority oversampling technique (SMOTE) method since the epitope class samples were in the minority compared to the nonepitope class. The experimental results obtained were compared and the most successful predictions were obtained with the random forest (RF) method. The epitope prediction performance in balanced datasets was found to be higher than that in the original datasets (94.0% AUC and 94.4% PRC for the SMOTE-SARS-CoV dataset; 95.6% AUC and 95.3% PRC for the SMOTE-B-cell dataset). In this study, 252 peptides out of 20312 peptides were determined to be epitopes with the SMOTE-RF-SVM hybrid method proposed for SARS-CoV-2 epitope prediction. Determined epitopes were analyzed with AllerTOP 2.0, VaxiJen 2.0 and ToxinPred tools, and allergic, nonantigen, and toxic epitopes were eliminated. As a result, 11 possible nonallergic, high antigen and nontoxic epitope candidates were proposed that could be used in protein-based COVID-19 vaccine design (“VGGNYNY”, “VNFNFNGLTG”, “RQIAPGQTGKI”, “QIAPGQTGKIA”, “SYECDIPIGAGI”, “STFKCYGVSPTKL”, “GVVFLHVTYVPAQ”, “KNHTSPDVDLGDI”, “NHTSPDVDLGDIS”, “AGAAAYYVGYLQPR”, “KKSTNLVKNKCVNF”). It is predicted that the few epitopes determined by machine learning-based in silico methods will help biotechnologists design fast and accurate vaccines by reducing the number of trials in the laboratory environment.

SARS-CoV-2 is a new type of coronavirus that presents with influenza-like symptoms in humans. Coronaviruses are viruses that typically have spikes in the surface region 1,2 . These pointed structures allow the virus to attach to the target cell. The coronavirus family is classified into 4 groups according to its genetic structure: alpha, beta, gamma and delta. Alpha and beta strains can infect mammalian species.

The genetic information of the nCoV-19 virus was identified and uploaded to GenBank 3 . SARS-CoV (severe acute respiratory syndrome) and MERS-CoV (Middle East respiratory syndrome) are also deadly coronaviruses that have emerged in recent years. The phylogenetic tree of the known coronavirus family is given in Figure 1 . It is clear that SARS-CoV, SARS-CoV-2, and MERS-CoV descended from the same ancestor 4 . SARS-CoV is the coronavirus most similar to SARS-CoV-2. The genome similarity of the two viruses has been reported to be 70% 4 . Similar to SARS-CoV, SARS-CoV-2 uses the antigen-converting enzyme 2 receptor, which is located in the lower respiratory tract of humans and allows human-to-human spread, to enter the target cell 5, 6 . SARS-CoV-2 is a 29.9 kb, single-stranded RNA virus 3 . Similar to other coronaviruses, SARS-CoV-2 contains open reading frames in its genome. Approximately one-third of the entire virus genome encodes 4 basic structural proteins.

These proteins include nucleocapsid, spike, envelope and membrane proteins 7 . It is the nucleocapsid protein that holds the genome of the virus. As Figure 2 shows, spike proteins are located on the outer surface of the virus.

This protein, which is effective in identifying the host cell, allows the virus to attach to the membrane of the target cell. After the virus binds to the host cell, proteases present in that cell open the spike protein of the virus, revealing a fusion peptide. Thus, the RNA of the virus disperses into the cell and allows it to spread to more cells by replicating itself 8 . This whole process shows that the spike protein plays an important role in the entry of the virus into the cell. Therefore, vaccine studies have focused on the spike protein. Since SARS-CoV-2 is a new virus and the vaccine and treatment methods are unknown, many people have died due to the virus. When the course of the disease is followed, it is seen that elderly individuals and people with weak immune systems have a more severe disease and are more likely to die. A weak immune system causes cells to be less able to fight and repair themselves 10 .

The immune system is the body's defense mechanism against all external factors such as viruses, germs or harmful substances. Although immune system cells are spread throughout the body, they are more concentrated in immune system organs such as the spleen, thymus, lymph node and bone marrow. When a foreign substance such as a virus enters the body or a cancer cell develops, the immune system begins to produce substances called antibodies to destroy them. Foreign substances are targeted and fight antibodies until they are destroyed. Since it has a kind of memory, the immune system uses every experience in the next fight 11 .

As shown in Figure 3 , there are 2 separate response mechanisms in the immune system, innate and adaptive.

When innate immunity encounters microbes and viruses, it quickly steps in and creates the first immune responses. This response recognizes specific molecules carried by microorganisms, but is not agent specific.

Since the innate immune system has no memory, it exhibits the same reaction in every encounter 12 . Adaptive immunity, on the other hand, is acquired in various ways, such as disease or externally administered vaccines and serum. Adaptive immune systems have memories so they can remember pathogens they have encountered before. Therefore, adaptive immune systems produce antigen-specific responses. Lymphocytes, a type of white blood cell produced in the bone marrow, can recognize and destroy disease agents 13 . J o u r n a l P r e -p r o o f There are 2 types of adaptive immune responses, humoral and cellular. The humoral response is elicited by proteins called antibodies formed by B lymphocytes. When B lymphocytes encounter an antigen, they produce antibodies that can target the antigen. Antibodies are a type of chemical substance called immunoglobulins. They are responsible for the elimination of extracellular pathogens 15 .

B-cells are responsible for the synthesis of antibody molecules called immunoglobulins and have a Y-shaped structure. B-cells have specific antigen receptors called B-cell receptors (BCR) on their surface. These receptors bind pathogens with immunoglobin molecules. A region of antigen recognized by a particular antibody or B-cell is called a B-cell epitope 16 . As shown in Figure 4 , there are 2 types of B-cell epitopes: continuous (linear) and discontinuous. Linear epitopes consist of continuous residues found in the antigen protein sequence. That is why it is also called a continues epitope. Discontinuous or conformational epitopes, in contrast, consist of noncontiguous residues in the antigen sequence 17 . Both epitopes play an important role in peptide-based vaccine studies. However, linear B-cell epitope estimation is performed within the scope of the study, since linear B-cell epitopes consist of peptides that can be used more easily to replace antigens for immunity and antibody production. The Immune Epitope Database (IEDB) is a publicly available database containing experimentally validated Tand B-cell epitope data presented in the literatüre 19 . It also includes epitopes identified for specific viruses such J o u r n a l P r e -p r o o f as SARS-CoV and MERS. Since SARS-CoV-2 is a new virus, limited information is available for vaccine and drug studies. However, when the structural proteins of SARS-CoV and SARS-CoV-2 are compared, as shown in Figure 5 , it is seen that the spike and nucleocapsid proteins are largely preserved for both viruses. This similarity shows that SARS-CoV data can be used in peptide-based vaccine studies 20 . Considering this similarity, epitope prediction was made for SARS-CoV-2, the spike protein. SARS-CoV and linear B-cell epitope information from IEDB were used to create the model. Although epitope data are not yet available for SARS-CoV-2, since the gene and protein sequence information is known, the characteristics of the virus and the epitopes in the pathogen can be predicted by machine learningbased in silico methods 21 . There are many studies in the literature on predicting the death of patients diagnosed with SARS-CoV-2 using machine learning/artificial intelligence algorithms, modeling the spread of infection 22, 23 , diagnosis with medical image analysis 24 , and forecasting the COVID-19 vaccination rate 25, 26 .

Producing vaccines against infectious diseases by conventional methods has proven time-consuming and very expensive. Vaccine candidates have been effectively identified in previous viruses (HPV, Ebola, Zika, and MERS) using in silico methods 27 . However, there is a gap in the literature on determining epitopes that can be used in vaccine design by using machine learning-based in silico methods and bioinformatics tools. Designing a useful and effective vaccine against new mutant viruses which escape COVID-19 vaccines or different viruses that may emerge in the future will be one of the biggest challenges scientists can face. As such, the determination of vaccine candidates with the traditional method in silico predictions is very important because of limited time and resources 27 .

Sohai et al. 28 used two in silico methods for T-cell epitope prediction. These are prediction methods based on SARS-CoV immunological data and peptide-HLA binding prediction methods due to genetic similarity. Quadeer et al. 29 presented positive T-cell immune responses against epitopes containing COVID-19 proteins from blood samples of COVID-19 patients. The authors compared the epitopes obtained by in vitro methods with the predicted epitopes and found that the methods using SARS-CoV immunological data were more in line with the experimental results in general.

Due to genetic similarity in our study, we aimed to predict the B-cell epitope for SARS-CoV-2 from SARS-CoV immunological data. In this context, there are a limited number of studies in the literature. While some researchers have performed epitope prediction on protein sequences, others have tried to identify candidate epitopes using protein and epitope sequence features. Grifoni et al. 30 utilized bioinformatics tools for B-and Tcell epitope prediction for SARS-CoV-2. The BepiPred 2.0 tool 31 for linear B-cell epitopes and the Discotope 2.0 tool 32 for conformational B-cell epitope prediction were used. Chen et al. 20 aimed to predict B-cell epitopes in the spike protein of SARS-CoV-2 and T-cell epitopes in the nucleocapsid protein. In the study, they determined the conserved regions of the virus by aligning the SARS-CoV-2 protein sequences obtained from the NCBI database with Clustal Omega. BepiPred and ABCPred 33 tools were used for linear B-cell epitope prediction. Estimation of T-cell epitopes in the nucleocapsid protein was made with the free online tool provided by IEDB. Shoukat et al. 34 proposed a method to classify T-cell responses by analyzing TCR beta information from people infected and uninfected with COVID-19. The proposed method aimed to detect protective immunity acquired through natural infection or vaccine-induced immunity. PCA and hierarchical clustering were applied to the sequence data separated into K-mers. Since the number of samples in the used dataset is small, the dataset is divided with hold one out. Accordingly, an accuracy value of 96% was obtained in the training data and 92.9% in the test data. SARS-CoV B-cell linear epitope prediction was performed using the Bayesian neural network classification method by Ghoshal et al. (2021) 35 . In this study, 85% prediction accuracy was obtained for the SARS-CoV dataset. Aleatoric and epistemic uncertainty methods were used to measure the uncertainty in epitope estimation. In this study, only SARS-CoV epitope prediction was carried out, and no prediction was made for SARS-CoV-2. Noumi et al. 36 used the attentional mechanism LSTM network for epitope prediction.

The results obtained were compared with the epitope sequences predicted by BepiPred 2.0 for the same protein sequences. In this study, the epitope peptide length was limited to 8-14 amino acids. The highest accuracy value was obtained as 0.79 for the case where the peptide length was 12. Jain et al. 37 made epitope predictions for SARS-CoV by using various machine learning methods and epitope and peptide properties. In this study, the dataset containing B-cell epitopes was used to develop the model, and the SARS-CoV dataset was used for testing. The most successful result was obtained with the ensemble learning model with an accuracy value of 87%.

The limited number of studies available on this topic is based on either analysis of protein sequences with bioinformatics tools or prediction using sequence features. Higher accuracy estimates are needed for the proposed epitope regions to be used as vaccine candidates. The motivation of this study is to propose a new and J o u r n a l P r e -p r o o f successful hybrid machine learning approach for SARS-CoV-2 by using physico-chemical and sequence-based features in proven datasets for SARS-CoV in combination with feature engineering and data preprocessing. We aimed to determine nonallergen, high antigen and nontoxic epitopes among them by performing bioinformatic analyses for the predicted epitopes. This study presents the following contributions:  To determine probable nonallergenic, highly antigenic and nontoxic epitopes that can be used in vaccine design against SARS-CoV-2.

It is anticipated that the findings obtained from this study can be used to design a fast, reliable and cost-effective vaccine, especially against SARS-CoV-2 and other viruses in the SARS family.

The flowchart followed in this study to identify epitopes that can be used in vaccine design is illustrated in Figure 6 . In the first stage, the performances of different machine learning methods for determining epitopes in the original datasets (SARS-CoV, B-cell) and SMOTE datasets are examined and compared. In the second step, the SARS-CoV-2 epitopes were predicted after the proposed hybrid method was trained with SARS-CoV and Bcell datasets. In the third stage, epitopes determined by machine learning methods are analyzed with bioinformatic tools (AllerTop, VaxiJen, ToxinPred), and probable nonallergen, antigen, and nontoxic epitopes are selected that can be used in the vaccine. Within the scope of our study, analyses and algorithms were developed using R programming.

J o u r n a l P r e -p r o o f Figure 6 Flowchart of determining SARS-CoV-2 epitopes in this study.

The datasets used in this study are publicly available and provided by the Kaggle database 38 . The database contains three datasets namely SARS-CoV, B-cell, and SARS-CoV-2. Details on these datasets are presented below.

The SARS-CoV dataset is labeled and consists of 520 samples (peptides). In this study, the SARS-CoV dataset was used for model training. The dataset contains 380 nonepitopes and 140 epitopes. Since the dataset is Table 1 , and the density of the variables according to the target variable is shown in Figure 7 . In the study, some variables were removed from the dataset by feature engineering, also some variables were Table 2 . The density distribution of the variables in the dataset according to the class label is presented in Figure 8 . The B-cell dataset contains the same variables as the SARS-CoV dataset. As with the SARS-CoV dataset, categorical variables were removed from the B-cell dataset. Position, protein length, and peptide length variables were added to the dataset. Position variable was obtained with (end_position -start_position)+1 formula, the protein length variable was obtained from the length of the protein sequence and the peptide length variable was obtained from the length of the peptide sequence variable. and there is no label information. Since the SARS-CoV-2 dataset was unlabeled, it was used as a test set. In other words, the SARS-CoV dataset was modeled with different algorithms, the method with a high success in modeling the data was determined, and the epitope estimation was made to use the SARS-CoV-2 dataset as the test set. Likewise, epitope prediction was performed using the B-cell dataset for the training set and the SARS-CoV-2 dataset for the test set. The obtained results were compared and the concurrence/intersection epitopes predicted by the models trained with both data (SARS-CoV, B-cell) were determined. The variables in the SARS-CoV-2 dataset are given in Table 3 and the density plot of the input variables is given in Figure 9 . J o u r n a l P r e -p r o o f Figure 9 Density plot of the variables in the SARS-CoV dataset.

The imbalanced distribution between labels in a dataset negatively affects training and testing performance while developing a model 39 . The imbalance in the dataset can be resolvable by different methods. Sampling methods aim to balance the class distribution in the training data by either repeating minority samples or generating new minority samples (oversampling) or removing samples from the majority class (undersampling) 40 . Various techniques have been proposed for oversampling and undersampling. Random subsampling is a non-intuitive method used to eliminate samples of a large number of classes to balance class distributions 41 . The disadvantage of this method is the potential to destroy useful or important samples. Therefore, the information to be learned from the data is lost. On the other hand in the over-sampling method, the samples in the minority class are increased synthetically and they are brought closer to the number of samples in the majority class 42 . In this study, the synthetic minority oversampling technique (SMOTE), which is one of the over-sampling techniques was used to balance the data 43 .

SMOTE is one of the most frequently used resampling methods proposed by Chawla et al. 43 . SMOTE starts from existing minority samples and interpolates to create new artificial minority samples. The overtraining data is created by the rotation of the actual data. This method first finds the k-nearest neighbors of each minority J o u r n a l P r e -p r o o f sample, then randomly selects one of its nearest neighbors. Creates a new minority class instance that connects the minority class instance and its nearest neighbor. This procedure repeats until both classes have an equal number of elements 43, 44 . In the study, 3 and 5 nearest neighbors were tried and 5-NN was used due to its success. The steps of the algorithm can be summarized as follows:

Step 1: The k nearest neighbors of each observation belonging to the minority class are searched,

Step 2: The difference between the observation belonging to the minority class and the observation with its k nearest neighbors (kNN) is taken,

Step 3: A random number (α) is chosen between (0,1), this number is multiplied by the difference found in Step 2,

Step 4: With the formulation in Eq. (1), a new synthetic observation is obtained.

Step 5: To generate the desired number of synthetic observations steps 1-4 are repeated.

In this study, the epitope prediction success of different machine learning methods was examined and compared.

The methods used in the study are briefly described below.

Decision Tree (DT) decides which class the new data belongs to based on past data. The method creates a treelike hierarchical structure during the training phase. Thanks to this hierarchical structure, the results are easily understandable and interpretable, and it is one of the most widely used methods because it can be easily adapted to real-life problems 45 . Trees begin with the root node and then propagate the information through internal nodes until it reaches the final leaf nodes. Each node is divided into sub-nodes with basic Yes/No or True/False questions. Deciding which feature will be root, internal nodes or leaf is important to obtain a strong decision tree.

It subsets the dataset according to the most important attribute in the dataset. The feature with the highest information gain is determined as the root node. Splitting is performed to create child nodes called decision nodes. The Gini index is calculated for the newly formed nodes until the model reaches the leaves. If the Gini score of the current node is better than the new nodes to be generated from this node, iteration is interrupted for the new node, and in this way, it is decided whether the node is a leaf or an internal node. The Gini index and entropy measures are the most commonly used methods for calculating the impurity of a node 46 .

is based on statistical learning theory. The basic operation in SVM is to estimate the most appropriate decision function that can separate the two classes from each other or obtain the hyper-plane that can best distinguish the two classes from each other 47 . The method was originally built forward J o u r n a l P r e -p r o o f to distinguish between two classes that can only be separated linearly. However, in some cases, since it is not possible to separate the data linearly, the model has been adapted and started to be used to separate nonlinear data. In cases where the data is not linearly separate, data is mapped to a high-dimensional feature space with the kernel function and it is tried to be separated linearly. Common kernel functions are of three types: sigmoid, polynomial, and radial-based functions 48 .

Logistic Regression (logistic) may also be called a linear regression model, but logistic regression uses a more complex cost function. This cost function is called the sigmoid function or the logistic function. The logistic regression hypothesis tends to limit the cost function between 0 and 1. Since linear functions can have a value greater than 1 or less than 0, they cannot be represented by linear functions 49  Learning of the created dataset is started.

 Learning is provided using a learning algorithm.

 In the first step, classification training is performed for each dataset created with bootstrap.

 Estimation is made by combining the results obtained from T learning models.

In this study, accuracy 54 , precision 55 , f-measure 56 The precision-recall curve is an effective evaluation criterion for unbalanced binary classification models due to its minority class focus. These metrics are calculated in Eq. (2), (3), (4) using the confusion matrix 60 given in (2)

Where, TP is True Positive, TN is True Negative, FP is False Positive and FN is False Negative.

There In Figure 11 , it is seen that the positive classes in the minority group approach the majority group. It is seen that class are in the majority of the datasets used in the study, the samples that are required to be classified belong to the positive (epitope) class. Because the positive label in the dataset indicates that a peptide is an epitope and is the information that will be used in vaccine design. In unbalanced datasets, classes with large sample numbers dominate in the learning phase, and some imbalances can be seen while classifying the observation values belonging to minority classes. In this study, it was examined how increasing the minority group samples in the dataset and making it balanced affects the performance of classification models, especially in predicting the positive (epitope) class. For this purpose, the original SARS-CoV dataset (520 samples) and the SMOTE dataset (758 samples) were divided into 80% training and 20% testing. The classification performances of the models in test sets were compared in Table 4 . As previously reported, positive samples, i.e. peptides which are the epitope, were tried to be determined in this study. As can be seen in Table 4 , samples belonging to the positive class, which were generally balanced with SMOTE, had better results than samples from the original dataset. The most successful method in classifying positive samples was the RF method with 85.5% accuracy, 80.8% precision, and 85.5% f-measure rate.

The class distribution of the original B-cell dataset and the dataset balanced with SMOTE is visualized in Figure   12 . 

The SAR-CoV-2 dataset used in the study consists of 20312 peptides. It is not possible to analyze and physically test so many peptides in vaccine design. Furthermore, since the dataset is unlabeled, it is not known which peptide is the epitope and therefore which peptide can be used in the vaccine design. After determining the machine learning method that successfully predicts epitopes in SARS-CoV and B-cell datasets, it is possible to make successful SARS-CoV-2 epitope prediction with this method.

In this study, SARS-CoV-2 epitope prediction was made using both SARS-CoV and B-cell datasets separately for training. After the proposed SMOTE-RF-SVM method was trained with the SARS-CoV dataset, the epitopes in the SARS-CoV-2 dataset were determined. With the proposed method, 1483 peptides were classified as epitopes (positive), and 18829 peptides were classified as nonepitopes (negative). Later, the B-cell dataset was used for training and the SARS-CoV-2 dataset was used for testing. Here, 1875 peptides were classified as epitopes (positive), and 18437 peptides were classified as nonepitopes (negative) were estimated with the proposed method. Peptides determined as epitopes in both classifications were selected and as a result, 252

peptides were identified as epitopes by the SMOTE-RF-SVM method.

After identifying possible epitope peptides with the proposed hybrid method, allergenicity, antigenicity and toxicity analysis of epitopes were performed with bioinformatics tools. For an epitope to be used in vaccine design, it must be nonallergen, antigen, and nontoxic. In this study, allergenicity, antigenicity, and toxicity analyzes were performed with AllerTop 2.0 61 , Vaxijen 2.0 62 , and ToxiPred 63 bioinformatics tools, respectively, this process and the results obtained are summarized in Figure 13 .

Flowchart of bioinformatics analysis stage in this study.

AllerTop 61 is a bioinformatics tool that estimates allergenicity. This tool has a database of 2427 allergens and 2427 nonallergens and classifies the test sample according to the kNN (k=1) method. A peptide to be used as a vaccine should not be allergic, that is, it should not be allergenic to the host system 64 . As seen in Figure 13 , allergenicity analysis was performed for 252 epitopes using the AllerTop 2.0 tool. According to the allergenicity analysis, it was determined that 129 peptides were nonallergen and 123 peptides were allergen. Obtained allergenicity analysis results are given in Table 6 . As a result of allergenicity and antigenicity analysis, 63 peptides were determined as nonallergen and antigen.

ToxinPred 63 tool was used to measure the toxicity of these peptides. Toxicity represents amount or degree of poisonous and measures the damaging capacity of a substance. In drug and vaccine design, the active substance is expected to be nontoxic. The ToxinPred web server estimates the toxicity of peptides based on their physicochemical properties using the SVM method. The results obtained by toxicity analyzing 63 nonallergen and antigen peptides from a biochemical perspective are given in Table 8 . SVM score of <0.0 indicates that the peptide is nontoxic. In order for the vaccine to initiate an immune response in the host cell, the epitope must have a hydrophilic nature 65, 66 . Low molecular weight indicates that the peptide is nontoxic and less allergenic 67 .

Nontoxic 62 peptides were determined and these are given in Table 8 . 

The SARS-CoV-2 virus continues to spread rapidly all over the world, naturally mutating. It has been determined that some mutations seen recently are more resistant to vaccines 68 . The rise of these mutant viruses could force the development of second-generation vaccines. It is important to determine the epitopes that can be used in vaccine design by in silico methods so that the production of a new generation vaccine can be fast, effective, and low cost. This study, aimed to identify candidate epitopes for epitope-based SARS-CoV-2 vaccine design with artificial intelligence/machine learning and bioinformatics tools.

SARS-CoV, B-cell and SARS-CoV-2 datasets were used in the study. Since the labeled SARS-CoV and B-cell datasets have an unbalanced distribution, the datasets were balanced with the SMOTE method. After increasing the positive class in the minority group with SMOTE, the classification performance of machine learning methods was compared with the original dataset. In the datasets balanced with SMOTE, the prediction success of epitopes was higher than that of original dataset, and the most successful results were obtained with the RF method. In Figure 14 , the prediction results of the RF method in the original and SMOTE datasets are presented with confusion matrices for comparison. with the SMOTE method, it is seen that the performance of the balanced dataset is considerably higher than of the original dataset. While PPV was 71% and RR was 80% in the original B-cell dataset, PPV increased to 91%

and RR to 90% in the SMOTE dataset. The results obtained from this study showed that the dataset balanced with SMOTE improved the performance of machine learning methods in epitope prediction. The performance of the machine learning methods to predict epitopes in the SMOTE SARS-CoV and SMOTE B-cell datasets are given in Table 9 . for B-cell). Furthermore, allergenicity, antigenicity and toxicity analyses of the determined SARS-CoV-2 epitopes were performed in our study.

It is important to identify peptides with high epitope potential from the SARS-CoV-2 proteins that can be used in the vaccine to reduce the experiments to be performed physically in the laboratory environment. With the proposed SMOTE-RF-SVM method, 252 of 20312 peptides were determined to be probable epitopes (positive).

For a peptide to be used in a vaccine, it must be nonallergenic, antigen, and nontoxic, in addition to being an epitope. Allergenicity, antigenicity and toxicity analyses of 252 peptides were performed using AllerTop,

VaxiJen and ToxinPred bioinformatics tools. It was determined that 62 of these epitopes are nonallergenic, antigenic and nontoxic. The threshold level for a peptide to be an antigen in the VaxiJen tool was selected by default as >0.4. However, in this study, a threshold level of ≥1.0 was chosen to identify good (high) antigen epitopes. As a result, 11 probable nonallergen, highly antigenic and nontoxic epitopes were selected from 20312 SARS-CoV-2 peptides that can be used for vaccine design. Analyses of the determined candidate epitopes are given in Table 10 . 

The COVID-19 outbreak showed that the world is not prepared for an epidemic and showed how important it is to design a rapid vaccine. It takes more than 15 years to develop a vaccine using conventional methods 69 . After COVID-19 was declared a state of emergency, large companies worked collaboratively to produce a vaccine J o u r n a l P r e -p r o o f quickly. Despite this, the first vaccination took more than a year, and millions of people died from the epidemic 25 . It seems possible to quickly design a vaccine for future epidemics by utilizing machine learning methods. The novelty of this study is to propose a successful method for epitope prediction and to show researchers the usability of machine learning and bioinformatics tools in vaccine design.

In the study, it was observed that the epitope prediction success of the models increased in general after the SARS-CoV and B-cell datasets used for model training were balanced. When the epitope prediction performances of ML methods were compared for the datasets balanced with the SMOTE method, it was seen that the RF method made more successful predictions than other methods. Epitopes determined by the developed hybrid approach (SMOTE-RF-SVM) were analyzed with the bioinformatics tools AllerTop, VaxiJen, ToxinPred, and allergen, antigen, and toxic epitopes not suitable for use in vaccine design were eliminated.

With the proposed SMOTE-RF-SVM hybrid approach, 252 positive epitope candidates that can be used in vaccine design were determined from 20312 peptides. Then, the AllerTop tool was used to determine nonallergen peptides, and it was determined that 123 of 252 candidate epitopes were allergen and 129 were nonallergen. Antigenicity and toxicity analyses were performed on nonallergen epitope candidates using the VaxiJen and ToxinPred tools, respectively. As a result of the analyses, 11 possible nonallergen, high antigen and nontoxic peptides were determined that can be used in the design of vaccines against SARS-CoV-2 ("VGGNYNY", "VNFNFNGLTG", "RQIAPGQTGKI", "QIAPGQTGKIA", "SYECDIPIGAGI", "STFKCYGVSPTKL", "GVVFLHVTYVPAQ", "KNHTSPDVDLGDI", "NHTSPDVDLGDIS", "AGAAAYYVGYLQPR", "KKSTNLVKNKCVNF"). It is anticipated that the findings from this study will help medical biotechnologists design fast, useful, and effective vaccines. 

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status

SARS-CoV-2 and coronavirus disease 2019: what we know so far

A novel coronavirus from patients with pneumonia in China

A systematic analysis of studies on corona virus disease 19 (COVID-19) from viral emergence to treatment

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Severe acute respiratory syndrome-related coronavirus: The species and its viruses-a statement of the Coronavirus Study Group

Genotype and phenotype of COVID-19: Their roles in pathogenesis

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Innate and adaptive immune responses against coronavirus

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine

The immune system

Innate immune recognition: mechanisms and pathways

The evolution of adaptive immune systems

Cytokines in cancer pathogenesis and cancer therapy

Immunology: essential and fundamental

Identification of conformational B-cell Epitopes in an antigen from its primary sequence

Fundamentals and methods for T-and Bcell epitope prediction

Computational approaches in antibody-drug conjugate optimization for targeted cancer therapy

The immune epitope database (IEDB): 2018 update

Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Infectious diseases of poverty

Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study

Estimation of COVID-19 prevalence in Italy

The machine learning approach for predicting the number of intensive care, intubated patients and death: The COVID-19 pandemic in Turkey

A new approach for computer-aided detection of coronavirus (COVID-19) from CT and X-ray images using machine learning methods

Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US

Forecasting the COVID-19 vaccine uptake rate: an infodemiological study in the US

Design an efficient multi-epitope peptide vaccine candidate against SARS-CoV-2: an in silico analysis. Infection and drug resistance

In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives. Advanced drug delivery reviews

Epitopes targeted by T cells in convalescent COVID-19 patients

A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2

BepiPred-2.0: improving sequence-based Bcell epitope prediction using conformational epitopes

Reliable B cell epitope predictions: impacts of method development and improved benchmarking

Prediction of continuous B-cell epitopes in an antigen using recurrent neural network

Use of machine learning to identify a T cell response to SARS-CoV-2

Uncertainty Estimation in SARS-CoV-2 B-Cell Epitope Prediction for Vaccine Development

Epitope prediction of antigen protein using attention-based LSTM network

Prediction modelling of COVID using machine learning methods from B-cell dataset. Results in physics

COVID-19/SARS B-cell Epitope Prediction

Learning imbalanced datasets with labeldistribution-aware margin loss. Advances in neural information processing systems

Improving imbalanced learning through a heuristic oversampling method based on k-means and SMOTE

Comparative studies among machine learning models for performance estimation and health monitoring of thermal power plants

Outlier-SMOTE: A refined oversampling technique for improved detection of COVID-19. Intelligence-based medicine

SMOTE: synthetic minority over-sampling technique

A study of the behavior of several methods for balancing machine learning training data

Data mining: a tutorial-based primer

Partitioning nominal attributes in decision trees

The nature of statistical learning theory

Deep learning

Applied logistic regression

KNN model-based approach in classification

Random forests

Bagging predictors. Machine learning

Using iterated bagging to debias regressions

Assessing the accuracy of prediction algorithms for classification: an overview

Representation quality in text classification: An introduction and experiment. Speech and Natural Language

Evaluation: from precision, recall and F-measure to ROC, informedness, markedness and correlation

The use of the area under the ROC curve in the evaluation of machine learning algorithms

The meaning and use of the area under a receiver operating characteristic (ROC) curve

An introduction to ROC analysis

An improved method to construct basic probability assignment based on the confusion matrix for classification problem

Bioinformatics tool for allergenicity prediction

VaxiJen: Prediction of Protective Antigens and Subunit Vaccines

Designing and prediction of toxic peptides

Immunoinformatics Identification of B-and T-Cell Epitopes in the RNA-Dependent RNA Polymerase of SARS-CoV-2

Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa

In silico approach for predicting toxicity of peptides and proteins

Physico-chemical, sensory and toxicity characteristics of dipeptidyl peptidase-IV inhibitory peptides from rice bran-derived globulin using computational approaches

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

SARS-CoV-2 vaccines in development

According to the allergenicity analysis, 129 nonallergen peptides were selected (Table 6 ) and their antigenicity score was calculated. For this, the VaxiJen 2.0 62 bioinformatics tool was used. VaxiJen makes an alignmentindependent prediction of protective antigens using the physicochemical properties of proteins. Antigenicity is based on the vaccine's ability to bind to B-cell receptors and increase the immune response in the host 64 . The default threshold value in the VaxiJen tool is 0.4, and epitopes with antigenicity higher than this value are called antigens. Antigenicity analysis results of 129 nonallergen epitopes are presented in Table 7 .